Chlorpheniramine / hydrocodone / phenylephrine Pregnancy and Breastfeeding Warnings
Brand names: Chemdal HD, Chemdal HD Plus, Chemtussin HC, Chlorgest HD, Cyndal HD, Ditussin-HC, Ed-TLC, Ed-Tuss HC, Efasin-HD, Endagen-HD, Endal-HD Plus, Endotuss-HD, Enplus-HD, Exo-Tuss, Guiaphen HD, Hydrocodone CP, Hyphen-HD, Iodal HD, Iotussin HC, KG-Dal HD, Mintuss MS, Nasatuss, Rindal-HD, Tuss-PD, Vanex-HD
Chlorpheniramine / hydrocodone / phenylephrine Pregnancy Warnings
Chlorpheniramine/hydrocodone/phenylephrine has been assigned to pregnancy category C by the FDA. Animal studies of hydrocodone have revealed evidence of teratogenicity. There are no controlled data in human pregnancy. Chlorpheniramine/hydrocodone/phenylephrine is only recommended for use during pregnancy when there are no alternatives and benefit outweighs risk.
Chlorpheniramine / hydrocodone / phenylephrine Breastfeeding Warnings
There are no data on the excretion of chlorpheniramine/hydrocodone/phenylephrine into human milk. The manufacturer recommends that due to the potential for serious adverse reactions in nursing infants, a decision should be made to discontinue nursing or discontinue the drug, taking into account the importance of the drug to the mother.
References for pregnancy information
- (2005) "Product Information. Tusana-D (chlorpheniramine/hydrocodone/phenylephrine)." Cypress Pharmaceutical Inc
References for breastfeeding information
- (2005) "Product Information. Tusana-D (chlorpheniramine/hydrocodone/phenylephrine)." Cypress Pharmaceutical Inc
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
